MONOCYCLIC COMPOUND HAVING GLP-1 RECEPTOR AGONIST ACTIVITY

Abstract

The present invention relates to a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof. A compound represented by formula (I): whereinA1 is C(R5) or N,A2 is C(R6) or N,A3 is C(R7) or N,R5, R6, and R7 are each independently a hydrogen atom or the like,R2 is substituted or unsubstituted alkyl or the like,-L- is a group represented by: whereinR1 is a hydrogen atom or the like,R8 is a hydrogen atom or the like,R10s are each independently cyano or the like,m is an integer of 1 to 3, andR3 is phenyl optionally substituted with substituent group F, or the like,the substituent group F: halogen, cyano, alkyl, haloalkyl, alkyloxy, and haloalkyloxy.

CPC Classifications